Fidelity Select Pharmaceuticals
Fidelity Select Portfolios82 Devonshire StreetBoston MA 02109
Map
Phone: 800-544-6666
| Category: | Health | | Fund Family: | Fidelity Investments | | Net Assets: | 910.47M | | Year-to-Date Return: | 7.25% | | Yield: | 1.19% | | Morningstar Rating: |  | | Fund Inception Date: | Jun 17, 2001 |
|
Andrew Oh
Lead Manager since Jul 30, 2006 | | | Oh joined Fidelity Investments in 2006 as an equity research analyst. Prior to Fidelity, he was director and senior pharmaceuticals analyst for Leernik Swann & Company in New York. From 2001 to 2004, he was senior equity research associate following the U.S. large cap pharmaceuticals sector for JP Morgan Chase in New York. |
| Min Initial Investment: | 2,500 | | Min Initial Investment, IRA: | 500 | | Min Initial Investment, AIP: | 2,500 | | Min Subsequent Investment: | N/A | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | 200 |
|
| |
| The investment seeks capital appreciation.
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified. |
| Last Dividend
(Apr 11, 2013)
:
| 0.06 | | Last Cap Gain
:
| 0.00 | | Annual Holdings Turnover
(May 15, 2013)
:
| 73.00% | | Average for Category: | 47.95% |
|
| Expense | FPHAX | Category Avg |
|---|
| Annual Report Expense Ratio (net): | 0.88% | 1.48% | | Prospectus Net Expense Ratio: | 0.89% | N/A | | Prospectus Gross Expense Ratio: | 0.89% | N/A | | Max 12b1 Fee: | N/A | N/A | | Max Front End Sales Load: | N/A | 5.28% | | Max Deferred Sales Load:
| N/A | 2.66% | | 3 Yr Expense Projection*: | 284 | 646 | | 5 Yr Expense Projection*: | 493 | 1,001 | | 10 Yr Expense Projection*: | 1,096 | 1,973 |
|
|
0.52%